Royalty Interest Purchase AgreementRoyalty Interest Purchase Agreement • August 30th, 2022 • Jaguar Health, Inc. • Pharmaceutical preparations • Utah
Contract Type FiledAugust 30th, 2022 Company Industry JurisdictionThis Royalty Interest Purchase Agreement (this “Agreement”), dated as of August 24, 2022, is entered into by and between Jaguar Health, Inc., a Delaware corporation (“Company”), and Streeterville Capital, LLC, a Utah limited liability company, its successors and/or assigns (“Investor”).
Confidential materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote such omission. ROYALTY INTEREST PURCHASE AGREEMENT Dated as of April 16, 2010 among DYAX CORP. and KGH Domestic III, LPRoyalty Interest Purchase Agreement • November 2nd, 2010 • Dyax Corp • Services-commercial physical & biological research • New York
Contract Type FiledNovember 2nd, 2010 Company Industry JurisdictionROYALTY INTEREST PURCHASE AGREEMENT (as amended, supplemented or otherwise modified from time to time, this “Agreement”) is made and entered into as of April 16, 2010 (the “Effective Date”) by and among DYAX CORP., a Delaware company ( “Dyax”) and KGH Domestic III, LP, a Delaware limited partnership (the “Buyer”).
ContractRoyalty Interest Purchase Agreement • May 5th, 2020 • New York
Contract Type FiledMay 5th, 2020 JurisdictionEX-10.1 2 v192040_ex10-1.htm Exhibit 10.1 EXECUTION VERSION Confidential materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote such omission. ROYALTY INTEREST PURCHASE AGREEMENT Dated as of April 16, 2010 among DYAX CORP. and KGH Domestic III, LP Exhibit 10.1 EXECUTION VERSION Confidential materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote such omission. ROYALTY INTEREST PURCHASE AGREEMENT ROYALTY INTEREST PURCHASE AGREEMENT (as amended, supplemented or otherwise modified from time to time, this “Agreement”) is made and entered into as of April 16, 2010 (the “Effective Date”) by and among DYAX CORP., a Delaware company ( “Dyax”) and KGH Domestic III, LP, a Delaware limited partnership (the “Buyer”). WHEREAS, Dyax wishes to sell, assign, convey and transfer to the Buyer, and the Buyer wishes to purchase from Dyax, the Royalty Interests (as defined below), upon and subject to the terms and co
FIRST AMENDMENT TO ROYALTY INTEREST PURCHASE AGREEMENT AND RELATED DOCUMENTSRoyalty Interest Purchase Agreement • July 14th, 2020 • Jaguar Health, Inc. • Pharmaceutical preparations • Utah
Contract Type FiledJuly 14th, 2020 Company Industry JurisdictionTHIS FIRST AMENDMENT TO ROYALTY INTEREST PURCHASE AGREEMENT AND RELATED DOCUMENTS (this “Amendment”) is entered into as of this 10th day of July, 2020 (the “Effective Date”), by and among Jaguar Health, Inc., a Delaware corporation (“Company”), and Iliad Research and Trading, L.P., a Utah limited partnership (“Investor”). Capitalized terms not otherwise defined herein shall have the meanings given to such terms in the Agreement (as defined below).